Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Kamada Ltd.

Market Cap 1.25B 125B 425M 367M 337M 316M 593M 40.66B 602M 4B 1.56B 19.62B 1.59B 1.56B 67.93B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 1.25B 125B 425M 367M 337M 316M 593M 40.66B 602M 4B 1.56B 19.62B 1.59B 1.56B 67.93B EV / Sales 2026 *
2.13x
EV / Sales 2027 * 1.94x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
1 day+0.61%
1 week+1.65%
Current month-2.48%
1 month-13.43%
3 months-22.53%
6 months-3.05%
Current year-4.47%
1 week 2,093
Extreme 2093
2,195
1 month 2,093
Extreme 2093
2,497
Current year 2,093
Extreme 2093
2,890
1 year 1,956
Extreme 1956
2,890
3 years 1,685
Extreme 1685
3,045
5 years 1,309
Extreme 1309
3,045
10 years 1,309
Extreme 1309
4,500
Manager TitleAgeSince
Chief Executive Officer 57 01/07/2015
Director of Finance/CFO 55 31/12/2017
Chief Operating Officer 53 01/11/2016
Director TitleAgeSince
Director/Board Member 64 24/12/2019
Chairman 77 07/03/2013
Director/Board Member 75 13/12/1990
Date Insider Type Main position Quantity % Market Cap.
04-07Free

Director

32,000 0.0555%
04-07Free

Chief Executive Officer

1,600,000 2.7738%
04-07Free

Chief Financial Officer

405,000 0.7021%
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%+1.65%-11.15%+12.33% 417M
+1.63%-1.21%+16.80%-18.09% 61.21B
+2.50%+7.58%+64.44%+216.37% 58.15B
-0.92%+28.60%+28.60%+28.60% 39.54B
+4.16%+16.25%-56.08%-64.88% 35.08B
+2.94%+2.04%+47.58%-35.26% 28.68B
+2.32%+10.05%+53.89%+76.65% 21.06B
+7.94%+1.18%+79.34%-59.73% 18.25B
-1.88%-5.07%-10.05%+93.76% 16.49B
+0.78%+0.78%+49.83%+98.01% 15.87B
Average +2.01%+1.23%+26.32%+34.78% 29.47B
Weighted average by Cap. +2.08%+1.44%+28.86%+43.93%

Financials

2026 *2027 *
Net sales 585M 58.47B 199M 172M 158M 149M 278M 19.09B 283M 1.88B 731M 9.21B 748M 732M 31.9B 642M 64.19B 219M 189M 174M 163M 306M 20.96B 310M 2.06B 802M 10.11B 822M 804M 35.01B
Net income 72.01M 7.2B 24.55M 21.19M 19.5M 18.3M 34.3M 2.35B 34.8M 231M 89.99M 1.13B 92.17M 90.18M 3.93B 104M 10.36B 35.34M 30.5M 28.06M 26.33M 49.36M 3.38B 50.08M 333M 130M 1.63B 133M 130M 5.65B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
462
Date Price Change Volume
11/06/26 2,159.00 ILa +0.61% 45,595
10/06/26 2,146.00 ILa 0.00% 27,942
09/06/26 2,146.00 ILa -0.09% 24,910
08/06/26 2,148.00 ILa -0.42% 36,219
05/06/26 2,157.00 ILa +1.17% 22,232
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KMDA Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!